Ranch Capital Advisors Inc. Myriad Genetics Inc Transaction History

Ranch Capital Advisors Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$24.13 - $32.63 $19,304 - $26,104	-800 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $5,994 - $7,331	200 Added 33.33%	800 $26,000
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $1,269 - $1,630	-50 Reduced 7.69%	600 $18,000
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $996 - $1,580	-50 Reduced 7.14%	650 $19,000
Q4 2020 Feb 16, 2021	BUY	$12.16 - $19.77 $8,512 - $13,839	700 New	700 $13,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.08B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Ranch Capital Advisors Inc. with notifications on news.